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Background: The prevalence and correlates of hardcore smokers, who have high daily cigarette consumption,
no quitting history and no intention to quit, have been studied in several western developed countries, but no
previous trials of smoking cessation have tested intervention effectiveness for these smokers. The current study
examined if hardcore smokers can benefit from smoking reduction intervention to achieve cessation, and explored
the underlying reasons.
Methods: A posteriori analysis was conducted on data from a randomized controlled trial of smoking reduction
intervention on 1,154 smokers who did not want to quit. Odds ratios of 7-day point prevalence of abstinence,
smoking reduction by at least 50% and quit attempt at the 6-month follow-up comparing subgroups of smokers
were analyzed.
Results: In hardcore smokers, the odds ratio comparing the quit rate between the intervention and control group
was 4.18 (95% CI: 0.51-34.65), which was greater than non-hardcore smokers (OR = 1.58, 95% CI: 0.98-2.54). The
number needed to treat for hardcore and non-hardcore smokers was 8.33 (95% CI: 5.56-16.67) and 16.67 (95% CI:
8.33-233.64), respectively. In smokers who did not have quit attempt experience and those who smoked more than
15 cigarettes daily, the odds ratio comparing intervention and control group was 3.29 (95% CI: 0.72-14.98) and 1.36
(95% CI: 0.78-2.36), respectively.
Conclusions: The a posteriori analysis provided pilot results that smoking reduction intervention may be effective
to help hardcore smokers to quit and reduce smoking. Having no previous quit attempt was identified as more
important than having large cigarette consumption in explaining the greater effectiveness of the intervention.
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Smoking kills 6 million people each year in the world [1].
About 60% of adult current smokers in developed coun-
tries, however, do not want to quit or plan to quit in the
near future [2]. Previous studies conceptualized hardcore
smokers as those who have never thought to quit, have
never taken any action to quit even if there is an easy way
to do so, or have become totally discouraged from previ-
ous failed quit attempts [3]. There has been no universal
definition for hardcore smokers, but three basic indicators
of smoking characteristics were often used to specifically
characterize hardcore smokers for epidemiological studies:* Correspondence: derekcheung@hku.hk
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The strong tobacco control measures in Hong Kong
have resulted in the lowest smoking prevalence in the
developed world [4]. The prevalence of daily smoking in
Hong Kong has been declining from 23.3% in 1982 to
10.7% in 2012 [5]. Using the representative data of smok-
ing from the government, we found that the proportion of
hardcore smokers increased from 21.8% in 2005 to 27.4%
in 2008 [6], which was higher than several developed
countries including the US [7], Canada [8], and England
[9], and was comparable with Norway and Italy [10,11].
Therefore, Hong Kong is facing the challenge of increas-
ing hardcore smokers coupled with declining smoking
prevalence.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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conducted on smokers who did not want to quit, which
showed that smoking reduction treatment does not re-
strain smokers to quit [12,13]. Conversely, the treatment
with pharmacological assistance enhances the reduction
and achieves eventual cessation outcomes [12,14-16]. A
systematic review on smoking reduction treatment, in-
cluding these trials, has concluded that the combination
of pharmacologic and behavioral interventions was ef-
fective to increase quit rate for those who initially had
no quitting intention [17]. Our Hong Kong randomized
controlled trial of smoking reduction for smokers with no
intention to quit found that smoking reduction intervention
with nicotine replacement therapy (NRT) and behavioral
counselling increased tobacco abstinence (Intervention
group 17.0% versus Control 10.2%, p = 0.01) and reduction
in cigarette consumption by at least 50% (50.9% versus
25.7%, p < 0.01, including quitters) at the 6-month follow-
up [18]. Yet, its effectiveness for different sub-groups of
smokers or hardcore smokers has not been examined.
To the best of our knowledge, no studies have explored
the smoking characteristics that might influence the
effectiveness of smoking reduction intervention. The
findings about the influential factors of quitting suc-
cess in such trials can inform which kind of smokers
can benefit from the quitting strategy through smok-
ing reduction.
The current a posteriori analysis, based on our pub-
lished RCT, aimed to examine if hardcore smokers can
benefit from smoking reduction intervention to achieve
cessation. The two research questions were: (1) Was the
intervention of smoking reduction equally effective for
hardcore and non-hardcore smokers to quit, attempt quit-
ting or reduce smoking? (2) Did smokers without quitting
experience or heavy cigarette consumption benefit from
the smoking reduction intervention?
Methods
Data
The archived data of our published randomized controlled
trial of a smoking reduction project on 1,154 smokers re-
cruited during October 2004 to April 2007 were analyzed
[18] (Clinical trial registration number: ISRCTN05172176
(http://www.controlled-trials.com)). All the participants
were daily smokers who were not willing to quit but
interested in reducing smoking. They were randomly
allocated to two intervention groups and one control
group (Additional file 1: Appendix A). Both intervention
group A1 (n = 479) and A2 (n = 449) received 15-minute
face-to-face counseling on smoking reduction by trained
smoking cessation counselors and free nicotine replace-
ment therapy (NRT) for eight weeks in total. The counsel-
ing emphasized the ultimate goal of complete cessation by
focusing on the importance of smoking reduction, howreduction is useful and effective when quitting is difficult,
and how to reduce (Additional file 2: Appendix B and
Additional file 3: Appendix C). The former group (A1)
also received a 3-minute counseling of adherence to NRT,
which followed the guidelines on adherence interven-
tions by the World Health Organization [19]. The control
group B (n = 226) received a 10-minute brief advice on
the health hazards of smoking and the importance of
smoking cessation at baseline only. All the subjects were
given a 12-page self-help quitting pamphlet, “Tips for Quit
Smoking”, produced by Hong Kong Council on Smoking
and Health.Outcome measures
Two primary outcomes at the 6-month follow-up, as in
the original protocol, were used for assessing the efficacy
of smoking reduction intervention on the hardcore and
non-hardcore smokers: (1) self-reported 7-day point
prevalence of tobacco abstinence, and (2) self-reported
reduction by at least 50% in daily cigarette consumption
compared with baseline. The third outcome, the rate of
using NRT over 4 weeks at the 3-month follow-up, was
not relevant here and thus excluded. In addition, self-
reported quit attempt at the 6-month follow-up, defined
as no smoking for at least 24 hours in the past 30 days,
was included.Definition for hardcore smoker
As no universal definition of hardcore smoker is available,
the following criteria which have been commonly used in
previous studies were used to define hardcore smokers:
(1) aged 26 years or above; (2) smoked daily for 5 or more
years; (3) smoked 15 cigarettes or more a day; (4) had no
intention to quit; and (5) had never attempted to quit
[8,10,20-22]. The threshold for age and the years of smok-
ing were included because youth smokers and smokers
with short smoking history have not reached to a stable
level of average daily assumption [3]. Although this defin-
ition of hardcore smokers has been criticized for its low
predictive validity of future cessation [21] and the variabil-
ity in the identification of hardcore smokers [8], they have
been commonly used in epidemiological studies of hard-
core smokers. All participants at baseline in this RCT met
the 4th criteria, hence the other 4 criteria were the deter-
mining criteria of hardcore smokers. Particularly note-
worthy is that both hardcore and non-hardcore smokers
in this study were all daily smokers who were not willing
to quit but willing to participate in an RCT to reduce
smoking. Also, we had very few subjects aged under 26
(n = 42, 4.3%) and had smoked for less than 5 years
(n = 21, 2.2%). Therefore, the differentiating factors for
hardcore smokers were “smoked 15 or more cigarettes a
day” and “had made no quit attempt in lifetime”.
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Rates of abstinence, quit attempt and smoking reduction
by at least 50% were compared between the intervention
group (A1 and A2) and control group (B) with odds ra-
tios and 95% confidence intervals adjusting for age
group and sex. The results were computed by intention-
to-treat approach such that all randomized subjects were
included in the analysis, where those who were lost to
follow-up were treated as failure to achieve the cessation
outcome. The retention rate at 6-month follow-up for
group A1, A2 and B was 89.1%, 94.4% and 95.6% (Add-
itional file 1: Appendix A), so that the outcome discrep-
ancy due to misclassifying those excluded subjects as
failure would be small. Number needed to treat (NNT),
which shows the number of treated subjects needed to
have one additional successful outcome, was computed
by taking the reciprocal of the risk difference between
the intervention and control group [23]. The breakdown
of the rates by hardcore or non-hardcore smokers,
smoked or did not smoke 15 or more cigarettes a day,
and had or had no previous quit attempt at baseline
were analyzed to examine the effectiveness of the smok-
ing reduction intervention for these sub-groups. To
examine any interaction effect between intervention ef-
fect and types of smokers (hardcore versus non-
hardcore, smoked versus did not smoke 15 or more cig-
arettes a day, and had versus had no previous quit at-
tempt at baseline) on the cessation outcomes, a
multivariate logistic regression was conducted to yield
an odds ratio and p-value for the interaction term. Al-
though p < 0.05 was considered as statistically signifi-
cant, the objective of the a posteriori analysis was to
provide ‘pilot’ or ‘proof of principle’ results for a larger
RCT in the future.Ethics approval
The study was approved by the Institutional Review
Board of the University of Hong Kong and Hospital Au-
thority Hong Kong West Cluster (Ref no: UW 03–103
T/103).Results
Additional file 4: Appendix D shows that hardcore and
non-hardcore smokers were similar in all the socio-
demographic characteristics. Figure 1 shows that the 6-
month quit rate for hardcore smokers in the interven-
tion group were 12%, but the control group was 0%. The
odds ratio comparing the quit rate between the interven-
tion and control group was 4.18 (95% CI: 0.51-34.65) in
hardcore smokers, which was much greater than non-
hardcore smokers (18.1% versus 12.0%, OR = 1.58, 95%
CI: 0.98-1.88). The NNT for hardcore smokers was 1/
0.12 = 8.33 (95% CI: 5.56-16.67), which was about halfthat for non-hardcore smokers (1/0.06 = 16.67, 95% CI:
8.33-233.64).
Hardcore smokers in this study had two major compo-
nent criteria: (i) smoked 15 or more cigarettes a day and
(ii) had no quit attempt before. Among those who
smoked more than 15 cigarettes a day, the odds ratio of
abstinence comparing the intervention and control
group was 1.36 (95% CI: 0.78-2.36), which was smaller
than that in those who smoked less (OR = 2.42, 95% CI:
1.03-5.65). (Figure 1) Among those smokers who had no
reported previous quit attempt, the odds ratio was 3.29
(95% CI: 0.72-14.98), which was twice that in those who
had quit attempt before (OR = 1.55, 95% CI: 0.95-2.53).
In hardcore smokers, receiving the intervention was
associated with higher rate of quit attempt (24.8% versus
8.8%, OR = 3.84 (95% CI 1.07-13.85), p = 0.04). How-
ever, such difference was not significant in non-hardcore
smokes (38.4% versus 32.3%, OR = 1.34 (95% CI 0.95-
1.88), p = 0.09) and other sub-groups of smokers. Using
smoking reduction by 50% as the outcome, the differ-
ence between the intervention and control group was
similar in all the sub-groups of smokers. The odds ratios
ranged from 2.23 to 3.41, which mean that the interven-
tion group achieved better outcome of reducing smoking
than the control group. As expected, probably because
of insufficient statistical power, most of the interactions
between group allocation and smoking characteristics in
the models were not significant. (Table 1) There was no
sufficient evidence that the effectiveness of the smoking
reduction intervention was moderated by “hardcore” sta-
tus, daily cigarette consumption and previous experience
of quit attempt at baseline.
Discussion
This a posteriori analysis on data from an RCT has
yielded new evidence on the effectiveness of smoking re-
duction intervention for hardcore smokers in increasing
abstinence, quit attempt and smoking reduction. There
was no significant interaction effect between group allo-
cation and baseline smoking quantity, and between
group allocation and quit attempt history. Hardcore
smokers who received the smoking reduction interven-
tion tended to have more abstinence and quit attempt
than non-hardcore smokers who received the same
intervention. Considering the outcome of quit attempt
and reducing smoking by at least a half, the effectiveness
of the intervention was not significantly different be-
tween smokers who had higher and lower cigarette con-
sumption, and between smokers with and without quit
attempt history.
The present study provided preliminary evidence that
smoking reduction intervention may be effective in
hardcore smokers, which is different from some
population-level studies that light smoking quantity and
Figure 1 Smoking cessation outcomes comparing intervention group (Group A1+A2) and control group (Group B) in (a) hardcore
smokers; (b) non hardcore smokers; (c) smokers whose daily cigarette consumption equal to or greater than 15; (d) smokers whose
daily cigarette consumption less than 15; (e) smokers without quit attempt experience; and (f) smokers with quit attempt experience
at baseline.
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[21,24,25]. The interaction between “hardcore smoker”
status and “intervention” was not statistically significant
probably due to the insufficient sample size, as theoriginal RCT was not designed for the present sub-
group analysis. But the odds ratios showed large differ-
ences between hardcore and non-hardcore smokers. It
was mainly due to the very low quit and quit attempt
Table 1 Analysis of the interaction effect on smoking cessation outcomes at the 6-month follow-up
Odds ratio (95% CI) p-value*
Interaction term Group allocation X Hardcore status
Dependent variable 7-day abstinence 2.81 (0.34, 23.07) 0.34
Dependent variable Any quit attempt (including quitters) 2.42 (0.67, 8.79) 0.18
Dependent variable Smoking reduction by at least 50% (including quitters) 0.72 (0.29, 1.84) 0.50
Interaction term Group allocation X Smokers whose daily cigarette consumption ≥15
Dependent variable 7-day abstinence 0.56 (0.21, 1.53) 0.26
Dependent variable Any quit attempt (including quitters) 0.73 (0.37, 1.46) 0.38
Dependent variable Smoking reduction by at least 50% (including quitters) 0.96 (0.46, 1.97) 0.90
Interaction term Group allocation X Smokers with quit attempt experience
Dependent variable 7-day abstinence 2.15 (0.45, 10.17) 0.33
Dependent variable Any quit attempt (including quitters) 1.34 (0.52, 3.42) 0.54
Dependent variable Smoking reduction by at least 50% (including quitters) 0.68 (0.29, 1.59) 0.38
*p-value for interaction term: group allocation (intervention versus control) X type of smokers (hardcore versus non-hardcore).
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finding that hardcore smokers without receiving the
intervention had zero quit rate after participating in an
RCT can confirm the value of the notion of ‘hardcore’.
Therefore, hardcore smokers can benefit from the smok-
ing reduction intervention, with a smaller NNT being
half of that for non-hardcore smokers. However, the
statistical power for confirming the effectiveness of the
intervention for the hardcore smokers was low due to
the small group size and wide confidence interval. Fu-
ture studies for exploring the effectiveness of various
smoking cessation program among hardcore smokers
with a large sample size are warranted.
Although the intervention emphasized reduction,
about one in four hardcore smokers, who had no quit at-
tempt experience and intention to quit at baseline,
attempted to quit within the study period. The odds ra-
tio of abstinence among smokers without a quit attempt
was greater than those with the experience. On the con-
trary, the odds ratio of abstinence among smokers with
higher cigarette consumption was smaller than those with
lower cigarette consumption. It suggested that no quitting
experience was more important than large cigarette con-
sumption in explaining the greater effectiveness of the
intervention. However, most previous population-level
studies have supported that smokers without previous ex-
perience of quit attempt have a lower likelihood to have
subsequent quit attempt than those who have such ex-
perience [24-26]. In this RCT, the smokers without quit
attempt experience might be more empowered and en-
couraged to quit with the alternative approach of smoking
reduction, as they did not want to achieve cessation
through abrupt cessation.
Several studies have found that smoking reduction inter-
vention with NRT and counseling are effective to help
smokers without quitting intention [12,15,16,18,27-29].Our results showed that around one-third of the smokers
with daily cigarette consumption over 15 and one-fourth
of the smokers who had no quitting experience attempted
to quit smoking after receiving the intervention. The ef-
fectiveness was different, but not significantly, between
smokers with higher and lower cigarette consumption,
and with and without quit attempt experience, which was
probably due to insufficient statistical power. These find-
ings have added new knowledge that smoking reduction
intervention helps smokers with hardcore smoking char-
acteristics to quit using gradual cessation with free NRT.
The hardening hypothesis expects that those who con-
tinue to smoke have an increasing resistance to social
pressure to quit smoking [30]. Our findings have provided
the first evidence (proof of concept evidence) that future
RCTs with larger sample size to test whether such pro-
gressive approach of smoking cessation can help hardcore
smokers to quit and reduce the hardening of the smokers
are warranted. Although previous studies supported that
reducing smoking do not undermine cessation motivation
and effort [14,18], the existing clinical practice guidelines
of treating tobacco use in the US do not recommend clini-
cians to suggest smoking reduction for smokers as such
advice may decrease the proportion of smokers willing
to make a quit attempt [31]. Our results suggested that
smoking reduction intervention might be an alternative
for hardcore smokers by motivating them to reduce smok-
ing first and then quit.
The main strengths of the present study are that the
data were from an RCT and the outcomes were assessed
with blindness to the hardcore or non-hardcore status of
the subjects. The RCT targeted smokers who had no
intention to quit, in which the data had a large number
of hardcore smokers to facilitate the present exploratory
analysis. The main limitations were the a posteriori na-
ture and sample size in categories, which limited the
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were willing to reduce and participate in the RCT. They
might be “less hardcore” than smokers who never seek
professional help for quitting. The findings of the greater
effectiveness of smoking reduction on hardcore smokers
are not definitive, but they can provide some proof of
principle evidence to support further and larger RCTs
on smoking reduction on hardcore smokers with the ul-
timate aim of quitting. Lastly, the current analysis relied
on self-reported smoking status of the participants. Co-
tinine level in urine was measured in the self-reported
quitters at the 6-month follow-up, but only 102 out of
181 quitters underwent the test, and, of them, 84 passed
the test. The result from the biochemical confirmation
was not used because of the low retention rate as major-
ity of quitters refused the test.
Conclusion
The a posteriori analysis of the RCT on smoking reduc-
tion intervention suggested that the intervention may be
effective to increase the rate of abstinence, quit attempt
and smoking reduction by at least 50% in hardcore
smokers. Having no experience of quit attempt was
more important than having large cigarette consumption
to explain the greater effectiveness of the intervention.
Smoking reduction intervention is an alternative to mo-
tivate hardcore smokers to reduce smoking first and
then quit. Further research is needed to derive conclu-
sions on the effect of smoking reduction for the hard-
core smokers.
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